For research use only. Not for therapeutic Use.
2-Desbenzoyl-2-tiglyl docetaxel(CAT: C000465) is a derivative of the well-known anticancer drug docetaxel. This compound acts by disrupting microtubule dynamics, leading to cell cycle arrest and apoptosis. In pharmaceutical chemistry, it is being investigated for its potential in oncology, particularly in the treatment of various solid tumors. Its modification enhances its pharmacological properties, making it a promising candidate in the field of cancer therapeutics, where docetaxel derivatives play a pivotal role in combating cancer cells’ proliferation and growth.
| Catalog Number | C000465 |
| CAS Number | 1887057-05-7 |
| Synonyms | (2b,5b,7a,10b,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl (2E)-2-Methylbut-2-enoate; Docetaxel Impurity A; |
| Molecular Formula | C₄₁H₅₅NO₁₄ |
| Purity | ≥95% |
| Solubility | Chloroform (Slightly), Ethyl Acetate (Slightly) |
| Appearance | White to Off-White Solid |
| Storage | -20°C, Hygroscopic |
| Reference | Vasu Dev, R., et al.: J. Pharm. Biomed. Anal., 40, 614 (2006), |
